Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty

BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Patient Saf Surg
Auteurs principaux: Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://ncbi.nlm.nih.gov/pubmed/33975621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13037-021-00295-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires